Nuveen Asset Management, LLC Ideaya Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 266,336 shares of IDYA stock, worth $7.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266,336

Previous 255,293 4.33%

Holding current value

$7.13 Million

Previous $8.96 Million 5.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $335,375 - $475,401	11,043 Added 4.33%	266,336 $8.44 Million
Q2 2024 Aug 09, 2024	SELL	$34.37 - $43.46 $3.64 Million - $4.6 Million	-105,789 Reduced 29.3%	255,293 $8.96 Million
Q1 2024 May 13, 2024	SELL	$34.2 - $47.13 $609,820 - $840,375	-17,831 Reduced 4.71%	361,082 $15.8 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $4.12 Million - $6 Million	-167,347 Reduced 30.64%	378,913 $13.5 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $447,273 - $631,957	-21,228 Reduced 3.74%	546,260 $14.7 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $4.38 Million - $8.39 Million	328,581 Added 137.54%	567,488 $13.3 Million
Q1 2023 May 15, 2023	SELL	$13.49 - $18.72 $2.43 Million - $3.37 Million	-180,082 Reduced 42.98%	238,907 $3.28 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $2.2 Million - $2.76 Million	152,173 Added 57.03%	418,989 $7.61 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $194,132 - $331,747	21,010 Added 8.55%	266,816 $3.98 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $796,527 - $1.34 Million	96,199 Added 64.3%	245,806 $3.39 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $366,212 - $786,799	32,756 Added 28.03%	149,607 $1.74 Million
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $167,851 - $215,362	-8,012 Reduced 6.42%	116,851 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	$17.26 - $27.08 $155,771 - $244,396	9,025 Added 7.79%	124,863 $3.35 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $659,428 - $921,937	37,130 Added 47.17%	115,838 $2.43 Million
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $51,224 - $90,326	-3,800 Reduced 4.61%	78,708 $1.85 Million
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $196,302 - $282,597	16,130 Added 24.3%	82,508 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $148,631 - $191,551	13,247 Added 24.93%	66,378 $834,000
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $190,740 - $986,642	53,131 New	53,131 $755,000

Others Institutions Holding IDYA

# of Institutions

216

Shares Held

80.8M

Call Options Held

69K

Put Options Held

20K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.29B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ideaya Biosciences, Inc. Transaction History